Olivier Richel
Nijmegen, GE, Netherlands
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 37 publications
Residual HIV viremia strongly increases cardiovascular disease incidence independent of classical risk factors.
Journal: The Journal of infection
Published: January 22, 2026
Exploring the pharmacokinetic mechanisms that affect bictegravir exposure during pregnancy.
Journal: The Journal of antimicrobial chemotherapy
Published: January 06, 2026
Earlier Initiation of Treatment Following HIV Acquisition Reduces Non-AIDS-defining Malignancy Risk.
Earlier Initiation of Treatment Following HIV Acquisition Reduces Non-AIDS-defining Malignancy Risk.
Journal: Clinical infectious diseases : an official publication of the Infectious Diseases Society of America
Published: June 18, 2025
Earlier initiation of treatment following HIV acquisition reduces non-AIDS-defining malignancy risk.
Earlier initiation of treatment following HIV acquisition reduces non-AIDS-defining malignancy risk.
Journal: Clinical infectious diseases : an official publication of the Infectious Diseases Society of America
Published: June 18, 2025
Factors promoting or hindering self-administered outpatient parenteral antimicrobial therapy: a systematic literature review.
Journal: The Journal of antimicrobial chemotherapy
Published: January 15, 2025
Stakeholder perspectives on the offer and acceptance of self-administration of outpatient parenteral antimicrobial therapy: a qualitative study.
Journal: The Journal of antimicrobial chemotherapy
Published: January 15, 2025
Occurrence and predictors of laboratory abnormalities during outpatient parenteral antimicrobial therapy - A multicenter cohort study to inform laboratory test monitoring.
Journal: The Journal of infection
Published: August 09, 2024
Impact of COVID-19, lockdowns and vaccination on immune responses in a HIV cohort in the Netherlands.
Journal: Frontiers in immunology
Published: July 04, 2024
Dolutegravir/Lamivudine Is Noninferior to Continuing Dolutegravir- and Non-Dolutegravir-Based Triple-Drug Antiretroviral Therapy in Virologically Suppressed People With Human Immunodeficiency Virus: DUALING Prospective Nationwide Matched Cohort Study.
Journal: Open forum infectious diseases
Published: October 19, 2023
GLP-1 agonists for people living with HIV and obesity, is there a potential?
Journal: HIV medicine
Published: March 14, 2023
Outcomes of Bariatric Surgery in People With Human Immunodeficiency Virus: A Retrospective Analysis From the ATHENA Cohort.
Journal: Clinical infectious diseases : an official publication of the Infectious Diseases Society of America
Published: March 06, 2023
Last Updated: 09/26/2026